Fresenius sells IV manufacturing site in Chile to Medifarma as part of streamlining efforts

Fresenius sells IV manufacturing site in Chile to Medifarma as part of streamlining efforts

Fresenius SE & Co. KGaA, a global healthcare company headquartered in Germany, announced the divestment of its intravenous (IV) manufacturing site in Chile, Laboratorio Sanderson S.A., to Medifarma, a pharmaceutical company based in Peru with a strong footprint in Latin America. The divestment aligns with Fresenius Kabi’s ongoing strategy to streamline its global production network […]

Caplin Point Laboratories subsidiary gets FDA final approval for Thiamine Hydrochloride Injection

Caplin Point Laboratories subsidiary gets FDA final approval for Thiamine Hydrochloride Injection

Caplin Point Laboratories said that its subsidiary Caplin Steriles has secured final approval for its abbreviated new drug application (ANDA) for Thiamine Hydrochloride Injection USP, 200 mg/2 mL (100 mg/mL) Multi-dose Vial from the US Food and Drug Administration (FDA). The approved product is a generic version of Fresenius Kabi USA’s THIAMINE HYDROCHLORIDE injection. It […]

Zydus Lifesciences gets FDA tentative approval for Levothyroxine Sodium generic

Zydus Lifesciences gets FDA tentative approval for Levothyroxine Sodium generic

Zydus Lifesciences (previously Cadila Healthcare), through its US subsidiary Zydus Pharmaceuticals (USA), has secured tentative approval for Levothyroxine Sodium for injection, 100 mcg/vial, 200 mcg/vial, and 500 mcg/vial from the US Food and Drug Administration (FDA). The approved product is a generic version of Levothyroxine Sodium injection manufactured by Fresenius Kabi USA. Levothyroxine Sodium injection […]

Fresenius Kabi launches Methocarbamol Injection in US for acute musculoskeletal conditions

Fresenius Kabi launches Methocarbamol Injection in US for acute musculoskeletal conditions

Fresenius Kabi, the global German healthcare company, has unveiled Methocarbamol Injection, USP in the United States, marking a significant expansion of its anesthesia and analgesia portfolio. The 100 mg per mL, 10 mL vial presentation is designed to assist in relieving the discomfort associated with acute, painful musculoskeletal conditions. This new injectable treatment, which can […]

Fresenius Kabi launches Omegaven for pediatric patients with parenteral nutrition-associated cholestasis in US

Fresenius Kabi launches Omegaven for pediatric patients with parenteral nutrition-associated cholestasis in US

Fresenius Kabi, a prominent German pharmaceutical company, has introduced Omegaven (fish oil triglycerides) injectable emulsion in the United States, targeting a critical need for pediatric patients suffering from parenteral nutrition-associated cholestasis (PNAC). This launch marks Omegaven as the first and only FDA-approved fish oil lipid emulsion specifically designed for children with PNAC, expanding its availability […]

Fresenius Kabi launches generic Arsenic Trioxide Injection in US to enhance oncology treatment options

Fresenius Kabi launches generic Arsenic Trioxide Injection in US to enhance oncology treatment options

German health care company Fresenius Kabi has announced the US launch of its new generic drug, Arsenic Trioxide Injection. This product, a generic version of Teva Pharmaceutical Industries’ leukemia treatment Trisenox, is set to offer a more affordable option for patients battling acute promyelocytic leukemia (APL). Arsenic Trioxide Injection for Acute Promyelocytic Leukemia Arsenic Trioxide […]